Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

Assessment of Ki67 and uPA/PAI-1 expression in intermediate-risk early stage breast cancers

Abstract Background The objective of this study was to compare the efficacy of biomarkers in assessing the risk of breast cancer recurrence in patients with node-negative or micrometastatic grade II breast cancer. Specifically, we compared risk assessments based on the St. Gallen clinicopathological...

Full description

Bibliographic Details
Main Authors: Elise Deluche, Laurence Venat-Bouvet, Sophie Leobon, Veronique Fermeaux, Joelle Mollard, Nadira Saidi, Isabelle Jammet, Yves Aubard, Nicole Tubiana-Mathieu
Format: Article
Language:English
Published: BMC 2017-09-01
Series:BMC Cancer
Subjects:
uPA/PAI-1
Ki67
Subtypes
Grade II
Breast cancer
Online Access:http://link.springer.com/article/10.1186/s12885-017-3648-z

Internet

http://link.springer.com/article/10.1186/s12885-017-3648-z

Similar Items